Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 5 | BMC Genomic Data

Fig. 5

From: Construction and validation of a fatty acid metabolism risk signature for predicting prognosis in acute myeloid leukemia

Fig. 5

The correlation between the fatty acid metabolism signature and clinicopathological features. A Heatmaps described the association of the signature with age, gender, FAB subtype, cytogenetic risk, leukocyte count, hemoglobin count and platelet count in training and validation cohort. B The FA scores of FAB subtypes in training and validation cohort (with t test). C The distribution of cytogenetic risk between high-risk and low-risk group (with Chi-square test). ns, no significance; *, P < 0.05; **, P < 0.01; ***, P < 0.001; ****, P < 0.0001

Back to article page